Indenrigs- og Sundhedsministeriet Due Diligence

Run due diligence on Indenrigs- og Sundhedsministeriet: check compliance and get alerts when suppliers or ownership change.

Denmark · owned by Government of Denmark (Denmark) · sum.dk · 23 vendors

The Danish Ministry of Interior and Health is a government ministry responsible for health policy, healthcare system administration, and interior affairs including municipal and regional governance. The ministry oversees various health agencies and implements national health initiatives including cancer care plans and psychiatric services.

Resilience scores

Technology vendors

Insights

Last updated 2026-09-18 · revision 113

23 direct vendors, 230 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Compliance

10 in-scope frameworks identified; showing 3.

Danish Health Act — No public evidence

The Indenrigs- og Sundhedsministeriet is the responsible authority for the Danish healthcare sector and is therefore directly bound by the Danish Health Act (Sundhedsloven).

Evidence: https://www.retsinformation.dk/eli/lta/2022/210, https://www.retsinformation.dk/eli/lta/2018/1286, https://www.retsinformation.dk/eli/lta/2016/1188, https://danskelove.dk/sundhedsloven/1, https://p4h.world/en/documents/the-health-service-act-of-denmark-2024/, https://national-policies.eacea.ec.europa.eu/youthwiki/chapters/denmark/72-administration-and-governance

GDPR (source) — Evidence found

As a public authority established in the EU (Denmark), the Ministry processes personal data of individuals in the EU and is therefore directly subject to the GDPR.

Evidence: https://bechbruun.com/expertise/tech-digitalisation-and-cybersecurity/gdpr-and-data-protection/the-danish-data-protection-act, https://www.dlapiperdataprotection.com/?t=law&c=DK, https://gdprhub.eu/Data_Protection_in_Denmark

NIS2 (source) — No public evidence

The Ministry falls under the 'public administration' and 'health' sectors, which are designated as 'Essential Entities' under the NIS2 Directive. As a large public entity in the EU, it is within the scope of the directive.

Evidence: https://www.bureauveritas.dk/en/vores-markeder/cybersecurity/nis2, https://nis2directive.eu/who-are-affected-by-nis2/, https://www.glocertinternational.com/resources/guides/nis2-applicability-essential-vs-important-entities/, https://en.digst.dk/digital-governance/nis-2/what-is-nis-2/nis-2-regulatory-framework/, https://digital-strategy.ec.europa.eu/en/policies/nis2-directive-denmark

Financials

Three-year financials

Financial Resilience Score: 9/10

As a Danish government ministry, Indenrigs- og Sundhedsministeriet enjoys exceptionally high financial resilience because approximately 97% of its departmental income is state appropriation (bevilling) via §16 of the Finance Act. Counterparty and credit risk is effectively that of the Danish sovereign state, which carries a top-tier credit standing. The ministry also maintains a substantial buffer with accumulated wage-cap savings of DKK 410.3M in 2023 and loan-frame utilization dropping from 81.4% in 2022 to 20.7% in 2023, indicating strong liquidity headroom. However, the department has shown some operational stress in the most recent reported year, moving from a small DKK 3.2M deficit in 2022 to a DKK 21.9M deficit in 2023, driven by post-merger relocation costs to Slotsholmsgade 10-12, higher rent and building maintenance costs, and a structural DKK 18.3M overrun in the Pharmaceutical Injury Compensation scheme (§16.11.27). These are being addressed via Finanslov 2024. Additionally, the ministry has been reorganized repeatedly, most recently on 3 June 2026 into 'Sundheds- og Kirkeministeriet,' introducing structural continuity risk. On the administered side, the ministry channels over DKK 265B in transfers to regions and municipalities, and faces ongoing programmatic pressure from healthcare demand (waiting times, psychiatry) that will keep spending pressure high.

Key strengths: 97% of departmental income from state appropriation, Backed by Danish sovereign credit, Accumulated wage-cap savings of DKK 410.3M (2023), Loan-frame utilization reduced from 81.4% to 20.7% (2022-2023), Positive equity of DKK 159.6M (2023), Administers over DKK 265B in annual transfers

Risk factors: Operating deficit widened from DKK 3.2M to DKK 21.9M (2022-2023), Post-merger relocation and building cost increases, Structural overrun in Pharmaceutical Injury Compensation scheme, Repeated ministerial reorganizations (most recently 3 June 2026), Persistent healthcare system demand pressure (psychiatry waiting times), FX exposure on USD-denominated WHO contribution

Revenue by geography

Revenue by product/service

Workforce by country

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report